Rosetta Genomics Licenses Italian Market Rights to miRNA Dx Suite to AXA Diagnostics

So far this year, Rosetta has found commercialization partners for the diagnostics in the Middle East, Canada, the US, and India.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.